Prospective Evaluation of Neuromediators During Treatment with Docetaxel in Castration Resistant Prostate Cancer.

Jost von Hardenberg,Maike Schwartz,Christian Bolenz,Christel Weiss,Thorsten Werner,Stefan Fuxius, Markus Mueller,Thomas Frangenheim,Elmar Heinrich

Journal of clinical oncology（2016）

引用 0|浏览19

暂无评分

摘要

e16609Background: Small-cell/neuroendocrine (SCNC) transformation in castration resistant prostate cancer (CRPC) treated with highly effective AR axis inhibitors has been observed. Similarly, it ha...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要